Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent rash on the face and lips

Aaron Samsula1, M Alan Menter

  • 1Division of Dermatology, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas 75246, USA.

Proceedings (Baylor University. Medical Center)
|November 10, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

Dermatology and therapy·2022
Same author

Erythema Ab Igne and Malignant Transformation to Squamous Cell Carcinoma.

Cutis·2021
Same author

Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).

Journal of the American Academy of Dermatology·2020
Same author

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2).

Journal of drugs in dermatology : JDD·2020
Same author

Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib.

Proceedings (Baylor University. Medical Center)·2019
Same author

IL-17 inhibitors for psoriasis.

Seminars in cutaneous medicine and surgery·2018
Same journal

Beyond timing: mobility may be the missing variable in venous thromboembolism prevention after traumatic brain injury.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Beyond comorbidity scores: medication burden as a window into surgical risk following ankle fracture fixation.

Proceedings (Baylor University. Medical Center)·2026
Same journal

The risk of primary lung cancer in ANCA-associated vasculitis: systematic review and meta-analysis.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Clinical presentation and treatment of a case of anti-signal recognition particle-positive immune-mediated necrotizing myopathy.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Nationwide analysis of adult nongonococcal native septic knee arthritis hospitalizations from 2016 to 2022.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Comparing the diagnostic performance of 19-gauge and 22-gauge needles in endoscopic ultrasound-guided liver biopsy: a systematic review and meta-analysis.

Proceedings (Baylor University. Medical Center)·2026
See all related articles